Assessing prostate, bladder and rectal doses during image guided radiation therapy - Need for plan adaptation?

Journal of Applied Clinical Medical Physics

Volumn 10, Issue 3, 2009, Pages 56-74

  Varadhan, Raj ^a,b   Hui, Susanta K ^b   Way, Sarah ^a   Nisi, Kurt ^a  

^a Minneapolis Radiation Oncology   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adaptive radiotherapy; Image guided radiotherapy; Plan adaptation

Indexed keywords

EID: 77749239743     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v10i3.2883     Document Type: Article

References (53)

1. Galvin JM, Ezzell G, Eisbrauch A, et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys. 2004;58(5):1616-34.
2. Chism DB, Horwitz EM, Hanlon Al, Pinover WH, Mitra RK, Manks GE. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 2003;55(1):71-77.
3. Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003;30(8):2089-115.
4. Levitt SH, Khan FM. The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys. 2001;51(4):871-90.
5. Tomé WA, Fowler JF. On cold spots in tumor subvolumes. Med Phys. 2002;29(7):1590-98.
6. Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56(1):89-105.
7. Kupelian PA, Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66(3):876-82.
8. Siewerdsen JH, Jaffray D. Cone-beam computed tomography with a flat-panel imager: magnitude and effects of x-ray scatter. Med Phys. 2001;28(2):220-31.
9. Yoo S, Yin FF. Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. Int J Radiat Oncol Biol Phys. 2006;66(5):1553-61.
10. Yang Y, Schreibmann E, Li T, Wang C, Xing L. Evaluation of on-board kV cone beam CT(CBCT)-based dose calculation. Phys Med Biol. 2007;52(3):685-705.
11. Lee L, Le OT, Xing L. Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys. 2008;70(2):634-44.
12. van Zijtveld M, Dirkz M, Heijmen B. Correction of conebeam CT values using a planning CT for derivation of the "dose of the day". Radiother Oncol. 2007;85(2):195-200.
13. Richter A, Hu Q, Steglich D, et al. Investigation of the usability of conebeam CT data sets for dose calculation. Radiat Oncol. 2008;3:42.
14. Curry TS, Dowdey JE, Murry RC. Christensen's Physics of Diagnostic Radiology. 4th Edition. Malvern, PA: Lea & Febiger; 1990.
15. Elekta Synergy Customer Acceptance tests for XVI R3.5. Crawley, UK: Elekta Limited Linac House; 2003.
16. Lehmann J, Perks, J, Semon S, Harse R, Purdy JA. Commissioning experience with cone-beam computed tomography for image-guided radiation therapy. J Appl Clin Med Phys. 2007;8(3):21-36.
17. Mutic S, Palta JR, Butker EK, et al. Quality assurance for computed-tomography simulators and the computed tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66. Med Phys. 2003;30(10):2782-92.
18. Ruchala KJ, Olivera GH, Kapatoes JM, Schloesser EA, Reckwerdt PJ, Machie TR. Megavoltage CT image reconstruction during tomotherapy treatments. Phys Med Biol. 2000;45(12):3545-62.
19. Langen KM, Meeks SL, Poole DO, et al. The use of megavoltage CT (MVCT) images for dose recomputations. Phys Med Biol. 2005;50(18):4259-76.
20. Schrim M, Yartsev S, Bauman G, Battista J, Van Dyk J. Consistency check of planned adaptive option on helical tomotherapy. Technol Cancer Res Treat. 2008;7(6):425-32.
21. Alasti H, Petric MP, Catton CN, Warde PR. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2001;49(3):869-84.
22. Birkner M, Yan D, Alber M, Liang J, Nüsslin F. Adapting inverse planning to patient and organ geometrical variation: algorithm and implementation. Med Phys. 2003;30(10):2822-31.
23. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med. 2005;23(1):14-24.
24. Chen J, Lee RJ, Handrahan D, Sause WT. Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: assessment of prostate organ motion. Int J Radiat Oncol Biol Phys. 2007;68(3):912-19.
25. Happersett L, Mageras GS, Zelefsky MJ, et al. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. Radiother Oncol. 2003;66(3):263-70.
26. Hoogeman MS, van Herk M, de Bois J, Lebesque JV. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radioth Oncol. 2005;74(2):177-85.
27. Jani AB. Organ motion and IMRT in prostate cancer therapy. Cancer J. 2003;9(4):244-46.
28. Keller H, Tomé W, Ritter MA, Mackie TR. Design of adaptive treatment margins for non-negligible measurement uncertainty: application to ultrasound-guided prostate radiation therapy. Phys Med Biol. 2004;49(1):69-86.
29. Landoni V, Saracino B, Marzi S, et al. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys. 2006;65(2):587-94.
30. Lattanzi J, McNeeley S, Donnelly S, et al. Ultrasound-based stereotactic guidance in prostate cancer - quantification of organ motion and set-up errors in external beam radiation therapy. Comput Aided Surg. 2000;5(4):289-95.
31. Little DJ, Dong L, Levy LB, Chandra A, Kuban DA. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys. 2003;56(5):1218-24.
32. Stroom JC, Koper PC, Korevaar GA, et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol. 1999;51(3):237-48.
33. van Herk M, Bruce A, Kroes AP, Shauman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 1995;33(5):1311-20.
34. Zhang M, Moiseenko V, Liu M, Craig T. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations. Phys Med Biol. 2006;51(2):269-85.
35. Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys. 2007;68(3):682-89.
36. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41(3):491-500.
37. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24(13):1990-96.
38. Cahlon O, Zelefsky MJ, Shippy A, et al. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys. 2008;71(2):330-37.
39. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol. 2006;176(4 Pt 1):1415-19.
40. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53(5):1097-105.
41. Loblaw DA, Cheung P. External beam irradiation for localized prostate cancer - the promise of hypofractionation. Can J Urol. 2006;13 Suppl 1:62-66.
42. Miles EF, Lee WR. Hypofractionation for prostate cancer: a critical review. Semin Radiat Oncol. 2008;18(1):41-47.
43. Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys. 2007;67(4):1099-105.
44. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, ThamesHD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 2002;52(1):6-13.
45. Chappell R, Fowler J, Ritter M. New data on the value of alpha/beta -evidence mounts that it is low. Int J Radiat Oncol Biol Phys. 2004;60(3):1002-03.
46. Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys. 2001;50(4):1021-31.
47. Wang JZ, Guerrero M, Li XA. How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys. 2003;55(1):194-203.
48. Nuver TT, Hoogeman MS, Remeijer P, van Herk M, Lebesque JV. An adaptive off-line procedure for radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67(5):1559-67.
49. Nijkamp J, Pos FJ, Nuver TT, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys. 2008;70(1):75-82.
50. Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48(1):289-302.
51. Yan D, Wong J, Vicini F, et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys. 1997;38(1):197-206.
52. Court LE, Dong L, Lee AK, et al. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;62(1):154-63.
53. Litzenberg DW, Balter JM, Lam KL, Sandler HM, Ten Haken RK. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys. 2005;63(1):123-33.